Upgrade to SI Premium - Free Trial

Truist Securities Weighs in on Biogen (BIIB) Following 2nd Reported Alzheimer's Death

November 28, 2022 9:26 AM
Truist Securities analyst Robyn Karnauskas weighed in on Biogen (NASDAQ: BIIB) following recent news of the second death reported for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Trader Talk

Next Articles